- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02166411
Laparoscopic Myomectomy Using Barbed or Conventional Sutures
March 12, 2020 updated by: Usama M Fouda, Cairo University
Laparoscopic Myomectomy Using Barbed or Conventional Sutures . A Randomized Controlled Trial
The aim of this study is to compare operative data and early postoperative outcomes of laparoscopic myomectomy using barbed sutures with those of laparoscopic myomectomy using conventional sutures .
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
• Till now , there is only one small randomized controllrd study (n=22 in each arm) which compared the use of barbed suture with conventional suture in laparoscopic myomectomy .The myoma bed was closed with either conventional polyglactin suture or unidirectional barbed suture .
The operative time was shorter in the barbed suture group (73.3 ± 21.4 min Vs.
80.7 ± 18.6 min) but this difference failed to reach statistical significance because of small sample size .
However, the time required to suture the myoma beds was significantly lower in the barbed suture group .
Study Type
Interventional
Enrollment (Actual)
92
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Obstetrics &Gynecology Department , Faculty of medicine ,Cairo university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- the presence of one to three symptomatic intramural or subserosal myomas (with largest fibroid diameter less than 10 cm).
Exclusion Criteria:
- submucosal myoma
- calcified myomas
- uterine size more than 16 weeks
- suspension of genital malignancy
- coagulation defects or concurrent anticoagulant therapy
- pregnancy
- compromised cardiopulmonary status
- previous treatment with gonadotropin-releasing hormone analogue
- contraindications for general anesthesia.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: myomectomy using barbed sutures
.Myoma bed is sutured with barbed sutures
|
A transverse incision will be made over the myoma using unipolar hook and a cleavage plane between the myoma and uterus will be developed by sharp dissection.
After the identification of the cleavage plane, the fibroid will be enucleated by means of adequate traction with a strong grasper and countertraction maneuvers with another grasping forceps .
Bipolar forceps will be used to coagulate bleeding points .
The myometrial edges will be reapproximated in one or two layers (according to the depth of the uterine wound) by using a 24-cm × 24-cm 0 polydioxanone double-armed suture on a 26-mm half-circle reverse cutting needle( STRATAFIX™ Spiral PDO Knotless Tissue Control Device, Ethicon Inc , Somerville, NJ, USA ).
|
|
ACTIVE_COMPARATOR: myomectomy using conventional sutures
Myoma bed is sutured with conventional sutures
|
A transverse incision will be made over the myoma using unipolar hook and a cleavage plane between the myoma and uterus will be developed by sharp dissection.
After the identification of the cleavage plane, the fibroid will be enucleated by means of adequate traction with a strong grasper and countertraction maneuvers with another grasping forceps .
Bipolar forceps will be used to coagulate bleeding points .
Myometrial edges will be re-approximated using 1-0 polyglactin 910 suture(VICRYL™.;
Ethicon Inc, Sommerville, NJ)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Operative time
Time Frame: During myomectomy operation
|
During myomectomy operation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Suturing time of myoma bed
Time Frame: During myomectomy operation
|
During myomectomy operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Mohamed Zayed, M.D,PhD, Cairo university ,Faculty of medicine , Obstetrics and Gynecology Department
- Study Director: Usama M Fouda, M.D,PhD, Cairo university ,Faculty of medicine , Obstetrics and Gynecology Department
- Principal Investigator: Khaled A Elsetohy, M.D,PhD, Cairo university ,Faculty of medicine , Obstetrics and Gynecology Department
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2014
Primary Completion (ACTUAL)
January 1, 2019
Study Completion (ACTUAL)
January 1, 2020
Study Registration Dates
First Submitted
June 16, 2014
First Submitted That Met QC Criteria
June 17, 2014
First Posted (ESTIMATE)
June 18, 2014
Study Record Updates
Last Update Posted (ACTUAL)
March 13, 2020
Last Update Submitted That Met QC Criteria
March 12, 2020
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- lap.myomectomy
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibroid
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingLeiomyoma | Fibroid | Fibroid Uterus | Leiomyoma, UterineUnited States
-
Virtual Tribunal MonasteryWithdrawnUterine Fibroids Affecting Pregnancy | Uterine Fibroids - 1St Diagnosis | Uterine Fibroid DegeneratedUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingLeiomyoma | Fibroid Uterus | Leiomyoma, Uterine | Fibroid Tumor | FibromyomaUnited States
-
Mansoura UniversityUnknownInfertility | FibroidEgypt
-
Ain Shams UniversityCompleted
-
University Magna GraeciaUnknown
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Johns Hopkins UniversityRecruitingFibroid UterusUnited States
-
Merit Medical Systems, Inc.RecruitingUterine FibroidAustralia, United Kingdom, United States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingLeiomyoma | FibroidUnited States
Clinical Trials on myomectomy using barbed sutures
-
Cairo UniversityUnknown
-
Cairo UniversityUnknownCesarean Section ScarEgypt
-
Aljazeera HospitalUnknown
-
Far Eastern Memorial HospitalCompleted
-
Winners ClinicCompletedFace Lift | Suspension Technique | Minimal Invasive SurgeryKorea, Republic of
-
Unity Health TorontoJohnson & JohnsonNot yet recruitingCardiovascular Disease | Surgical Site Infection | Mediastinitis | Superficial Sternal Wound Infection
-
Sunnybrook Health Sciences CentreUnknown
-
Sohag UniversityRecruitingObstructive Sleep ApneaEgypt
-
Kanuni Sultan Suleyman Training and Research HospitalEnrolling by invitation